Impact of sex, race and socioeconomic status on survival after pulmonary thromboendarterectomy for chronic thromboembolic pulmonary hypertension

被引:6
|
作者
Su, Austin Y. [1 ]
Vinogradsky, Alice [1 ]
Wang, Amy S. [1 ]
Ning, Yuming [2 ]
Abrahams, Elizabeth [3 ]
Bacchetta, Matthew [4 ,5 ]
Kurlansky, Paul [1 ]
Rosenzweig, Erika B. [3 ]
Takeda, Koji [1 ]
机构
[1] Columbia Univ, Dept Surg, Div Cardiothorac & Vasc Surg, Med Ctr, New York, NY 10032 USA
[2] Columbia Univ, Ctr Innovat & Outcomes Res, Dept Surg, New York, NY 10032 USA
[3] Columbia Univ, Dept Pediat, Div Pediat Cardiol, Med Ctr, New York, NY 10032 USA
[4] Vanderbilt Univ, Med Ctr, Dept Thorac Surg, Nashville, TN USA
[5] Vanderbilt Univ, Med Ctr, Dept Cardiac Surg, Nashville, TN USA
关键词
Pulmonary thromboendarterectomy; Chronic thromboembolic pulmonary hypertension; Socioeconomic status; Distressed communities index; Outcome disparities; ETHNICITY;
D O I
10.1093/ejcts/ezac364
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES: Pulmonary thromboendarterectomy (PTE) is a definitive treatment for chronic thromboembolic pulmonary hypertension. Demographic-based disparities in PTE outcomes have not been well-studied. METHODS: We reviewed all patients who underwent PTE for chronic thromboembolic pulmonary hypertension between 2009 and 2019 at our institution, tracking demographic information including self-identified race, preoperative characteristics and 2-year survival. Socioeconomic status was assessed using the zip code-linked Distressed Communities Index, a validated holistic measure of community well-being. Survival was estimated using Kaplan-Meier method and factors associated with mortality were estimated using Cox regression. RESULTS: Of 235 PTE patients, 101 (42.9%) were white and 87 (37.0%) were black. White patients had a higher median age at surgery (57 vs 51 years, P = 0.035) and a lower degree of economic distress (33.6 vs 61.2 percentile, P < 0.001). Regarding sex, 106 (45.1%) patients were male and 129 (53.6%) were female. Male patients had a higher median age (59 vs 50 years, P = 0.004), greater rates of dyslipidaemia (34% vs 20.2%, P = 0.025), a lower ejection fraction (55% vs 57%, P = 0.046) and longer cross-clamp (77 vs 67.50 min, P = 0.004) and circulatory arrest times (42 vs 37.50 min, P = 0.007). No difference was observed in unadjusted 2-year survival after PTE between patients stratified by race and sex (P = 0.35). After adjustment for clinically relevant variables, neither socioeconomic status, sex nor race were associated with mortality in Cox proportional hazard analysis. CONCLUSIONS: Sex, socioeconomic status and race were not associated with adverse outcomes after PTE in our single-centre experience.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] Pulmonary Thromboendarterectomy in 106 Patients With Chronic Thromboembolic Pulmonary Hypertension
    Lopez Gude, Maria Jesus
    Perez de la Sota, Enrique
    Forteza Gil, Alberto
    Centeno Rodriguez, Jorge
    Eixeres, Andrea
    Teresa Velazquez, Maria
    Sanchez Nistal, Maria Antonia
    Perez Vela, Jose Luis
    Ruiz Cano, Maria Jose
    Gomez Sanchez, Miguel Angel
    Escribano Subias, Pilar
    Cortina Romero, Jose Maria
    ARCHIVOS DE BRONCONEUMOLOGIA, 2015, 51 (10): : 502 - 508
  • [22] The treatment of choice in chronic thromboembolic pulmonary hypertension: Pulmonary thromboendarterectomy
    Perez Guillen, Manuel
    CIRUGIA CARDIOVASCULAR, 2018, 25 (02): : 73 - 76
  • [23] Pulmonary thromboendarterectomy: An advance in the treatment of chronic thromboembolic pulmonary hypertension
    McKane, CL
    HEART & LUNG, 1998, 27 (05): : 293 - 296
  • [24] Early results of pulmonary thromboendarterectomy for chronic thromboembolic pulmonary hypertension
    Mayer, E
    Kramm, T
    Dahm, M
    Moersig, W
    Eberle, B
    Duber, C
    Menzel, T
    Oelert, H
    ZEITSCHRIFT FUR KARDIOLOGIE, 1997, 86 (11): : 920 - 927
  • [25] Effects of Pulmonary Thromboendarterectomy in Patients with Chronic Thromboembolic Pulmonary Hypertension
    Kim, Hyun Kuk
    Hong, Suck Chan
    Lee, Jae Won
    Hong, Sang-Bum
    Oh, Yeon-Mok
    Shim, Tae Sun
    Lim, Chae-Man
    Koh, Younsuck
    Kim, Woo Sung
    Kim, Dong Soon
    Kim, Won Dong
    Lee, Sang-Do
    TUBERCULOSIS AND RESPIRATORY DISEASES, 2005, 59 (06) : 644 - 650
  • [26] Clinical Predictors Of Improvement After Pulmonary Thromboendarterectomy In Patients With Chronic Thromboembolic Pulmonary Hypertension
    Matthews, D. T.
    Le, C.
    Petracek, M.
    Pugh, M. E.
    Robbins, I. M.
    Hemnes, A. R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [27] RIGHT VENTRICULAR DYSSYNCHRONY IMPROVES AFTER PULMONARY THROMBOENDARTERECTOMY IN CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION
    Wong, Darrin
    Yousefian, Omid
    Auger, William
    Madani, Michael
    Dittrich, Mary
    Daniels, Lori
    Raisinghani, Ajit
    DeMaria, Anthony
    Blanchard, Daniel
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (13) : 2063 - 2063
  • [28] Exercise capacity before and after pulmonary thromboendarterectomy in patients with chronic thromboembolic pulmonary hypertension
    Falcone, C
    D'Armini, AM
    Buzzi, P
    Monterosso, C
    Maniaci, D
    Leonardi, S
    Tavazzi, L
    Viganó, M
    CIRCULATION, 2003, 108 (17) : 523 - 524
  • [29] An Analysis of Pulmonary Arterial Hypertension Targeted Medication Before and After Pulmonary Thromboendarterectomy for Chronic Thromboembolic Pulmonary Hypertension
    Bates, Dina
    Fernandes, Timothy
    Auger, William
    Kerr, Kim
    CHEST, 2015, 148 (04)
  • [30] Impact of Preoperative Left Ventricular Ejection Fraction on Outcomes After Pulmonary Thromboendarterectomy for Chronic Thromboembolic Pulmonary Hypertension
    Almodovar-Cruz, G. E.
    Hayashi, H.
    Zhao, Y.
    Rosenzweig, E. B.
    Takeda, K.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2024, 43 (04): : S449 - S450